Information Provided By: 
Fly News Breaks for May 25, 2016
ICPT
May 25, 2016 | 07:58 EDT
Morgan Stanley analyst Andrew Berens sees unfavorable risk/reward into Intercept's Ocaliva May 29 action date given high expectations. Berens continues, Expectations are very high for approval and, more importantly, the quality of the label granted. The analyst sees pricing risk and launch skepticism pressuring shares and reiterates his Underweight rating and $80 price target.
News For ICPT From the Last 2 Days
There are no results for your query ICPT
